|
This report is being submitted as part of remediation activities associated with capa 643143, addressing mdr reporting guidance from the fda¿s 1995 preamble, which ensures complaints related to corrections and recalls previously reported to the fda under 21 cfr 806 are now reported as mdrs; this is not a new malfunction/event.Product analysis: upon receipt of the suspect complaint device at medtronic¿s quality laboratory with the capsule partially open and a valve loaded in the capsule, visual analysis showed the handle is not intact.The deployment knob components were received loose and detached from the device.The tabs have detached from one of the deployment knob components.The tabs were not received with the device.The carriage components were received loose and detached from the device.The trigger appears intact.The device was returned with the end cap/screw gear snap fit connected.The capsule is partially retracted upon receipt with the valve partially exposed.A kink is observed along the distal end of the exposed inner member.A void is observed along the proximal end of the capsule.Conclusion: the device history record was reviewed and showed this product met all manufacturing specifications for product released for distribution.No issues were identified that would have impacted this event.Various factors can affect valve positioning, such as patient anatomy or physician experience.It was reported that the valve was recaptured to re-position deployment, which is a feature of the device that allows for additional attempts at accurately positioning the valve, but the deployment knob (actuator) separated during recapture.Actuator separation is typically associated broken or damaged snap fit tabs, either one tab or both, which hold the handle together.An actuator separation will prevent loading and/or deployment through normal use.Analysis of the returned dcs confirmed the reported actuator knob separation.Additionally, voids were observed on the capsule, which indicate delamination between the capsule outer polymer and the nitinol frame, and typically occur when the capsule is subjected to a bending force potentially after tracking through tortuous anatomy, or if a valve has been misloaded.Overall, device analysis indicates no findings to suggest a device quality deficiency related to the manufacturing of the device.Wide open aortic regurgitation on the previously implanted surgical valve was reported while waiting for the second valve; it is possible that the degenerative condition of the previously implanted bioprosthetic valve leaflets, which is the indication for this valve, in addition to interference with attempted valve implant may have led to the regurgitation.There was no information to suggest a device quality deficiency related to this event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|